Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.
David M FoureauManisha BhutaniFei GuoKatherine RigbyMarina LeonidasElise TjadenAndee FoxShebli AtrashBarry PaulPeter M VoorheesSaad Z UsmaniPublished in: Cancer medicine (2021)